{
  "metadata": {
    "version": "2.0",
    "last_updated": "2025-07-17",
    "description": "Enhanced clinical trial data extraction keywords for melanoma research",
    "extraction_priority": ["nct_number", "treatment_arms", "efficacy", "safety"]
  },
  "validation_rules": {
    "critical_fields": {
      "nct_number": {
        "required": true,
        "validation": "regex:NCT\\d{8}",
        "extraction_patterns": [
          "NCT\\d{8}",
          "ClinicalTrials.gov.*NCT\\d{8}",
          "Clinical trial information:.*NCT\\d{8}"
        ],
        "action_if_missing": "TERMINATE"
      }
    },
    "controlled_vocabularies": {
      "cancer_type": [
        "Resected Cutaneous Melanoma",
        "Unresectable Cutaneous Melanoma",
        "Cutaneous melanoma with Brain metastasis",
        "Cutaneous Melanoma with CNS metastasis",
        "Uveal Melanoma",
        "Mucosal Melanoma",
        "Acral Melanoma",
        "Basal Cell Carcinoma",
        "Merkel Cell Carcinoma",
        "Cutaneous Squamous Cell Carcinoma"
      ],
      "clinical_trial_phase": [
        "Stage I",
        "Stage I/II",
        "Stage II",
        "Stage II/III",
        "Stage III",
        "Stage III/Stage IV",
        "Stage IV"
      ],
      "line_of_treatment": [
        "Neoadjuvant",
        "First Line",
        "2nd Line",
        "3rd Line+"
      ],
      "sponsors": [
        "Industry-Sponsored",
        "non Industry-Sponsored"
      ],
      "trial_names": [
        "Keynote-\\d+",
        "Checkmate-\\d+",
        "Masterkey-\\d+",
        "No Name"
      ]
    }
  },
  "field_groups": {
    "publication_metadata": {
      "fields": [
        {
          "name": "Publication Name",
          "type": "string",
          "format": "Journal YYYY; Volume:Pages",
          "example": "NEJM 2017; 377:1345-56",
          "required": true
        },
        {
          "name": "Publication Year",
          "type": "integer",
          "validation": {"min": 1990, "max": 2030},
          "required": true
        },
        {
          "name": "PDF number",
          "type": "string",
          "required": false
        }
      ]
    },
    "trial_identification": {
      "fields": [
        {
          "name": "NCT Number",
          "type": "string",
          "validation": "regex:NCT\\d{8}",
          "required": true,
          "critical": true
        },
        {
          "name": "Trial name",
          "type": "controlled_vocabulary",
          "vocabulary": "trial_names",
          "required": true
        },
        {
          "name": "Sponsors",
          "type": "controlled_vocabulary",
          "vocabulary": "sponsors",
          "required": true
        },
        {
          "name": "Clinical Trial Phase",
          "type": "controlled_vocabulary",
          "vocabulary": "clinical_trial_phase",
          "required": true
        }
      ]
    },
    "study_characteristics": {
      "fields": [
        {
          "name": "Cancer Type",
          "type": "controlled_vocabulary",
          "vocabulary": "cancer_type",
          "required": true
        },
        {
          "name": "Primary endpoint",
          "type": "string",
          "required": false
        },
        {
          "name": "Secondary endpoint",
          "type": "string",
          "required": false
        },
        {
          "name": "Median Age",
          "type": "numeric",
          "format": "years",
          "required": false
        }
      ]
    },
    "treatment_details": {
      "fields": [
        {
          "name": "Mechanism of action",
          "type": "string",
          "required": false
        },
        {
          "name": "Target Protein",
          "type": "string",
          "required": false
        },
        {
          "name": "Type of therapy",
          "type": "string",
          "therapy_classification": {
            "Immune Checkpoint Inhibitors": ["Pembrolizumab", "Nivolumab", "Ipilimumab", "Relatlimab"],
            "Cellular Therapy": ["Lifileucel", "Amtagvi", "TIL therapy"],
            "Targeted Therapy": ["Vemurafenib", "Dabrafenib", "Trametinib", "Encorafenib"],
            "Oncolytic Virus Therapy": ["Talimogene laherparepvec", "Imlygic"],
            "Chemotherapy": ["Dacarbazine", "Temozolomide", "Fotemustine"],
            "Bispecific Antibodies": ["Tebentafusp-tebn", "Kimmtrak"],
            "Vaccine/Immunostimulant": ["Cancer vaccines", "immunostimulants"]
          },
          "required": false
        },
        {
          "name": "Dosage",
          "type": "string",
          "required": false
        },
        {
          "name": "Type of dosing",
          "type": "string",
          "required": false
        },
        {
          "name": "Number of doses per year",
          "type": "numeric",
          "required": false
        }
      ]
    },
    "biomarkers": {
      "fields": [
        {
          "name": "Biomarker Inclusion",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        },
        {
          "name": "Biomarkers Inclusion Criteria",
          "type": "string",
          "required": false
        },
        {
          "name": "Biomarkers Exclusion Criteria",
          "type": "string",
          "required": false
        }
      ]
    },
    "geography_timeline": {
      "fields": [
        {
          "name": "Major country where clinical trial is conducted",
          "type": "string",
          "required": false
        },
        {
          "name": "Study start date",
          "type": "date",
          "format": "YYYY-MM-DD",
          "required": false
        },
        {
          "name": "Study completion date",
          "type": "date",
          "format": "YYYY-MM-DD",
          "required": false
        },
        {
          "name": "First results",
          "type": "date",
          "format": "YYYY-MM-DD",
          "required": false
        },
        {
          "name": "Trial run in Europe",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        },
        {
          "name": "Trial run in US",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        },
        {
          "name": "Trial run in China",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        }
      ]
    }
  },
  "arm_specific_fields": {
    "treatment_identification": {
      "fields": [
        {
          "name": "Generic name",
          "type": "string",
          "format": "Drug name or Drug A + Drug B for combinations",
          "required": true,
          "critical": true
        },
        {
          "name": "Brand name",
          "type": "string",
          "required": false
        },
        {
          "name": "Line of Treatment",
          "type": "controlled_vocabulary",
          "vocabulary": "line_of_treatment",
          "required": true
        },
        {
          "name": "Number of patients",
          "type": "numeric",
          "format": "integer",
          "required": true,
          "critical": true
        }
      ]
    },
    "company_information": {
      "fields": [
        {
          "name": "Company EU",
          "type": "string",
          "required": false
        },
        {
          "name": "Company US",
          "type": "string",
          "required": false
        },
        {
          "name": "Company China",
          "type": "string",
          "required": false
        },
        {
          "name": "Biosimilar",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        }
      ]
    },
    "prior_treatment_status": {
      "fields": [
        {
          "name": "Chemotherapy Naive",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        },
        {
          "name": "Chemotherapy Failed",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        },
        {
          "name": "Immune Checkpoint Inhibitor (ICI) Naive",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        },
        {
          "name": "Immune Checkpoint Inhibitor (ICI) failed",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        },
        {
          "name": "Ipilimumab-failure or Ipilimumab-refractory",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        },
        {
          "name": "Anti PD-1/L1-failure or Anti PD-1/L1-refractory",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        }
      ]
    },
    "mutation_status": {
      "fields": [
        {
          "name": "Mutation status",
          "type": "string",
          "required": false
        },
        {
          "name": "BRAF-mutation",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        },
        {
          "name": "NRAS-Mutation",
          "type": "binary",
          "format": "YES/NO",
          "required": false
        }
      ]
    },
    "efficacy_endpoints": {
      "response_rates": {
        "fields": [
          {
            "name": "Objective response rate (ORR)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Complete Response (CR)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Pathological Complete Response (pCR)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Complete Metabolic Response (CMR)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Disease Control Rate or DCR",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Clinical Benefit Rate (CBR)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Duration of Response (DOR) rate",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          }
        ]
      },
      "survival_rates": {
        "pfs_rates": {
          "fields": [
            {
              "name": "Progression free survival (PFS) rate at 6 months",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Progression free survival (PFS) rate at 9 months",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Progression free survival (PFS) rate at 12 months",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Progression free survival (PFS) rate at 18 months",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Progression free survival (PFS) rate at 24 months",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Progression free survival (PFS) rate at 48 months",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            }
          ]
        },
        "os_rates": {
          "fields": [
            {
              "name": "Overall survival (OS) rate at 6 months",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Overall survival (OS) rate at 9 months",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Overall survival (OS) rate at 12 months",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Overall survival (OS) rate at 18 months",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Overall survival (OS) rate at 24 months",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Overall survival (OS) rate at 48 months",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            }
          ]
        }
      },
      "survival_metrics": {
        "fields": [
          {
            "name": "Median Progression free survival (PFS)",
            "type": "numeric",
            "format": "months",
            "required": false
          },
          {
            "name": "Length of measuring PFS",
            "type": "numeric",
            "format": "months",
            "required": false
          },
          {
            "name": "p-value of PFS",
            "type": "categorical",
            "values": ["Non-Significant", "Significant", "Highly Significant"],
            "required": false
          },
          {
            "name": "Hazard ratio (HR) PFS",
            "type": "numeric",
            "format": "decimal",
            "required": false
          },
          {
            "name": "Median Overall survival (OS)",
            "type": "numeric",
            "format": "months",
            "special_values": ["NR"],
            "required": false
          },
          {
            "name": "Length of measuring OS",
            "type": "numeric",
            "format": "months",
            "required": false
          },
          {
            "name": "p-value of OS",
            "type": "categorical",
            "values": ["Non-Significant", "Significant", "Highly Significant"],
            "required": false
          },
          {
            "name": "Hazard ratio (HR) OS",
            "type": "numeric",
            "format": "decimal",
            "required": false
          },
          {
            "name": "Event-Free Survival (EFS)",
            "type": "numeric",
            "format": "months",
            "required": false
          },
          {
            "name": "p-value of EFS",
            "type": "categorical",
            "values": ["Non-Significant", "Significant", "Highly Significant"],
            "required": false
          },
          {
            "name": "Hazard ratio (HR) EFS",
            "type": "numeric",
            "format": "decimal",
            "required": false
          },
          {
            "name": "Recurrence-Free Survival (RFS)",
            "type": "numeric",
            "format": "months",
            "required": false
          },
          {
            "name": "p-value of RFS",
            "type": "categorical",
            "values": ["Non-Significant", "Significant", "Highly Significant"],
            "required": false
          },
          {
            "name": "Length of measuring RFS",
            "type": "numeric",
            "format": "months",
            "required": false
          },
          {
            "name": "Hazard ratio (HR) RFS",
            "type": "numeric",
            "format": "decimal",
            "required": false
          },
          {
            "name": "Metastasis-Free Survival (MFS)",
            "type": "numeric",
            "format": "months",
            "required": false
          },
          {
            "name": "Length of measuring MFS",
            "type": "numeric",
            "format": "months",
            "required": false
          },
          {
            "name": "Hazard ratio (HR) MFS",
            "type": "numeric",
            "format": "decimal",
            "required": false
          },
          {
            "name": "Time to response (TTR)",
            "type": "numeric",
            "format": "months",
            "required": false
          },
          {
            "name": "Time to Progression (TTP)",
            "type": "numeric",
            "format": "months",
            "required": false
          },
          {
            "name": "Time to Next Treatment (TTNT)",
            "type": "numeric",
            "format": "months",
            "required": false
          },
          {
            "name": "Time to Treatment Failure (TTF)",
            "type": "numeric",
            "format": "months",
            "required": false
          },
          {
            "name": "Median Duration of response or DOR",
            "type": "numeric",
            "format": "months",
            "required": false
          }
        ]
      }
    },
    "safety_endpoints": {
      "general_adverse_events": {
        "fields": [
          {
            "name": "Adverse events (AE)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Treatment emergent adverse events (TEAE)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Treatment-related adverse events (TRAE)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          }
        ]
      },
      "grade_3_plus_adverse_events": {
        "fields": [
          {
            "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 higher adverse events (AE)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 higher treatment emergent adverse events (TEAE)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 higher treatment-related adverse events (TRAE)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 higher treatment-emergent adverse events (TEAE)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          }
        ]
      },
      "severe_adverse_events": {
        "fields": [
          {
            "name": "Grade 4 treatment emergent adverse events",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Grade 5 treatment emergent adverse events",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Serious Adverse Events (SAE)",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Serious treatment emergent adverse events",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Serious treatment related adverse events",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          }
        ]
      },
      "treatment_discontinuation": {
        "fields": [
          {
            "name": "Treatment-emergent adverse events (TEAE) led to treatment discontinuation",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Adverse events (AEs) leading to discontinuation",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Treatment-emergent adverse events (TEAE) led to death",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          },
          {
            "name": "Adverse Events leading to death",
            "type": "percentage",
            "format": "numeric_only",
            "required": false
          }
        ]
      },
      "specific_adverse_events": {
        "immune_related": {
          "fields": [
            {
              "name": "Immune related adverse events (irAEs)",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Immune related adverse events (irAEs)",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Cytokine Release Syndrome or CRS",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Cytokine Release Syndrome or CRS",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            }
          ]
        },
        "hematologic": {
          "fields": [
            {
              "name": "White blood cell (WBC) decreased",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Thrombocytopenia",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Neutropenia",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Leukopenia",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Anemia",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Neutrophil count decreased",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 White blood cell (WBC) decreased",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            }
          ]
        },
        "gastrointestinal": {
          "fields": [
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Nausea",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Diarrhea",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Colitis",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Constipation",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            }
          ]
        },
        "respiratory": {
          "fields": [
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Dyspnea",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Cough",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Pneumonia",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Pneumonitis",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            }
          ]
        },
        "endocrine": {
          "fields": [
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Hyperglycemia",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Thyroiditis",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Hypophysitis",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            }
          ]
        },
        "hepatic": {
          "fields": [
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Hepatitis",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Alanine aminotransferase",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            }
          ]
        },
        "other_systemic": {
          "fields": [
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Pyrexia",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Bleeding",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Pruritus",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            },
            {
              "name": "Grade ≥3 or Grade 3+ or Grade 3-5 or Grade 3-4 Rash",
              "type": "percentage",
              "format": "numeric_only",
              "required": false
            }
          ]
        }
      }
    }
  },
  "extraction_guidelines": {
    "data_formats": {
      "percentage": {
        "description": "Extract numeric value only, no % symbol",
        "example": "25% → 25",
        "validation": "0-100"
      },
      "numeric": {
        "description": "Extract numeric value only, no units",
        "example": "12.5 months → 12.5",
        "validation": "positive_number"
      },
      "binary": {
        "description": "YES or NO only",
        "validation": ["YES", "NO"]
      },
      "months": {
        "description": "Extract months value, special handling for 'not reached'",
        "example": "12.0 (8.2–17.1) months → 12.0",
        "special_values": ["NR", "not reached"]
      }
    },
    "treatment_arm_rules": {
      "combination_format": "Drug A + Drug B",
      "different_doses": "Treat as separate arms",
      "patient_count": "Unique per arm, not cumulative"
    },
    "missing_data_handling": {
      "empty_string": "Use \"\" for missing values",
      "never_infer": "Do not guess or infer missing data",
      "explicit_only": "Extract only explicitly stated information"
    }
  }
} 